Exhibit 99.1


                          SECURITIES PURCHASE AGREEMENT

                                     BETWEEN

                          FRANKLYN RESOURCES III, INC.

                                       AND

                       BARRON PARTNERS LP, JCAR FUNDS LTD.
                           STEVE MAZUR AND RAY RIVERS

                                      DATED

                                  JUNE 2, 2006






                          SECURITIES PURCHASE AGREEMENT

      This SECURITIES PURCHASE AGREEMENT (the "Agreement") is made and entered
into as of the 2nd day of May, 2006 between Franklyn Resources III, Inc., a
corporation organized and existing under the laws of the State of Nevada (the
"Company") and Barron Partners LP, a Delaware limited partnership ("Barron"),
and the other investors named in Schedule A to this Agreement, Barron and the
other investors being collectively referred to as the "Investors" and each,
individually, an "Investor."

                                    RECITALS

      WHEREAS, the Investors wish to purchase from the Company, upon the terms
and subject to the conditions of this Agreement, for the Purchase Price as
hereinafter defined, (a) the Company's convertible subordinated promissory notes
(the "Notes") in the principal amount of three million five hundred thousand
dollars ($3,500,000) the Notes to be in the form attached hereto as Exhibit A,
(b) three hundred sixty nine thousand (369,000) shares (the "Initial Shares") of
Common Stock, and (c) Common Stock Purchase Warrants (the "Warrants") to
purchase up to six million (6,000,000) shares of Common Stock of the Company at
an exercise price of eighty five cents ($.85) per share, six million (6,000,000)
shares of Common Stock of the Company at an exercise price of one and 20/100
dollars ($1.20) per share and six million (6,000,000) shares of Common Stock of
the Company at an exercise price of one and 75/100 dollars ($1.75) per share.
The Note will be convertible into shares of Series A Preferred Stock or Common
Stock, as such terms are hereinafter defined, in the manner set forth in the
Notes; and

      WHEREAS, pursuant to a separate agreement, but as part of the transaction
whereby the Investor is purchasing the Notes, the Initial Shares and Warrants,
Skywide Capital Management Limited, a British Virgin Island company, and
Eastpride Capital Limited, a British Virgin Island company, as the sole
stockholders of Sinoenergy Holding Limited, a British Virgin Island company
("Sinoenergy"), which is the sole stockholder of Qingdau Sinogas General
Machinery Corporation, a Chinese corporation ("Sinogas"), are acquiring fourteen
million two hundred fifteen thousand three hundred eighty five (14,215,385)
shares of Common Stock in exchange for all of the outstanding common stock or
other equity interests in Sinoenergy, with the result that Sinoenergy is a
wholly-owned subsidiary of the Company and Sinogas is a wholly-owned subsidiary
of Sinoenergy; and

      WHEREAS, the parties intend to memorialize the purchase and sale of the
Notes, the Initial Common Stock and the Warrants.

      NOW, THEREFORE, in consideration of the mutual covenants and premises
contained herein, and for other good and valuable consideration, the receipt and
adequacy of which are hereby conclusively acknowledged, the parties hereto,
intending to be legally bound, agree as follows:





                                   ARTICLE I

                   INCORPORATION BY REFERENCE AND DEFINITIONS

1.1.  Incorporation by Reference. The foregoing recitals and the Exhibits and
      Schedules attached hereto and referred to herein, are hereby acknowledged
      to be true and accurate, and are incorporated herein by this reference.

1.2.  Supersedes Other Agreements. This Agreement, to the extent that it is
      inconsistent with any other instrument or understanding among the parties,
      shall supersede such instrument or understanding to the fullest extent
      permitted by law. A copy of this Agreement shall be filed at the Company's
      principal office.

1.3.  Certain Definitions. For purposes of this Agreement, the following
      capitalized terms shall have the following meanings (all capitalized terms
      used in this Agreement that are not defined in this Article 1 shall have
      the meanings set forth elsewhere in this Agreement):

            1.3.1. "4.9% Limitation" has the meaning set forth in Section 2.1.3
      of this Agreement.

            1.3.2. "1933 Act" means the Securities Act of 1933, as amended.

            1.3.3. "1934 Act" means the Securities Exchange Act of 1934, as
      amended.

            1.3.4. "Affiliate" means a Person or Persons directly or indirectly,
      through one or more intermediaries, controlling, controlled by or under
      common control with the Person(s) in question. The term "control," as used
      in the immediately preceding sentence, means, with respect to a Person
      that is a corporation, the right to the exercise, directly or indirectly,
      of more than 50% of the voting rights attributable to the shares of such
      controlled corporation and, with respect to a Person that is not a
      corporation, the possession, directly or indirectly, of the power to
      direct or cause the direction of the management or policies of such
      controlled Person.

            1.3.5. "Articles" means the Articles of Incorporation of the
      Company, as the same may be amended from time to time.

            1.3.6. "Bylaws" means the bylaws of the Company, as the same may be
      amended from time to time.

            1.3.7. "Certificate of Designation" means the certificate of the
      rights, preferences and privileges, subject to the limitations, with
      respect to the Series A Preferred Stock, pursuant to Article Fourth of the
      Restated Articles. The Certificate of Designation shall be in
      substantially the form of Exhibit B to this Agreement, subject to the
      provision of Section 6.5 of this Agreement.

                         SECURITIES PURCHASE AGREEMENT
                                     PAGE 2


            1.3.8. "Closing" means the consummation of the transactions
      contemplated by this Agreement and the Exchange of Securities, all of
      which transactions shall be consummated contemporaneously with the
      Closing.

            1.3.9. "Closing Date" means the date on which the Closing occurs,
      which be not later than May 31, 2006.

            1.3.10. "Common Stock" means the Company's common stock, which is
      presently designated as the common stock, par value $.001 per share.

            1.3.11. "Company's Governing Documents" means the Articles and
      Bylaws.

            1.3.12. "Convertible Securities" means the Notes and the Series A
      Preferred Stock.

            1.3.13. "EBITDA" means consolidated earnings before interest, taxes,
      depreciation and amortization, determined in accordance with U.S. GAAP.

            1.3.14. "Escrow Agreement" means the Escrow Agreement among the
      Company, the Investors and Katsky Korins LLP, as Escrow Agent, attached
      hereto as Exhibit C it being acknowledged that the Escrow Agent is counsel
      for the Company.

            1.3.15. "Exchange of Securities" means the issuance of shares of
      Common Stock in exchange for the outstanding securities of Sinoenergy, as
      described in the second recital.

            1.3.16. "Exempt Issuance" means the issuance of (a) shares of Common
      Stock or options to employees, officers, directors of and consultants
      (other than consultants whose services relate to the raising of funds) of
      the Company pursuant to the Company's 2006 long-term incentive plan and
      any other stock or option plan that was or may be adopted by a majority of
      the non-employee members of the Board of Directors of the Company or a
      majority of the members of a committee of non-employee directors
      established for such purpose, (b) securities upon the exercise of or
      conversion of any securities issued hereunder and pursuant to the
      Registration Rights Agreement, the Notes, the Warrants and the Certificate
      of Designation and any other options, warrants or convertible securities
      which are outstanding on after completion of the Closing and the
      effectiveness of the Exchange of Securities, and (c) securities issued
      pursuant to acquisitions, licensing agreements, or other strategic
      transactions, provided any such issuance shall only be to a Person which
      is, itself or through its subsidiaries, an operating company in a business
      which the Company's board of directors believes is beneficial to the
      Company and in which the Company receives benefits in addition to the
      investment of funds, but shall not include a transaction in which the
      Company is issuing securities primarily for the purpose of raising capital
      or to an entity whose primary business is investing in securities.

                         SECURITIES PURCHASE AGREEMENT
                                     PAGE 3


            1.3.17. "GAAP" means United States generally accepted accounting
      principles consistently applied.

            1.3.18. "Initial Shares" shall have the meaning set forth in the
      first recital.

            1.3.19. "Material Adverse Effect" means any adverse effect on the
      business, operations, properties or financial condition of the Company
      that is material and adverse to the Company and its subsidiaries, taken as
      a whole and/or any condition, circumstance, or situation that would
      prohibit or otherwise materially interfere with the ability of the Company
      to perform any of its material obligations under this Agreement or the
      Registration Rights Agreement or to perform its obligations under any
      other material agreement.

            1.3.20. "Net Income" means net income determined in accordance with
      GAAP plus (a) any charges relating to the transaction contemplated by this
      Agreement and the Registration Rights Agreement, and (b) any other
      non-recurring items, including the issuance of warrants which are not
      issued under a stock option or other equity-based incentive plan.

            1.3.21. "Nevada Act" means Section 78 of the Nevada Revised
      Statutes, as amended.

            1.3.22. "Person" means an individual, partnership, firm, limited
      liability company, trust, joint venture, association, corporation, or any
      other legal entity.

            1.3.23. "Pre-Tax Income" means income before income taxes determined
      in accordance with GAAP plus (a) any charges relating to the transaction
      contemplated by this Agreement and the Registration Rights Agreement, and
      (b) any other non-recurring items, including the issuance of warrants
      which are not issued under a stock option or other equity-based incentive
      plan.

            1.3.24. "Purchase Price" means the three million five hundred
      thousand dollars ($3,500,000) to be paid by the Investors to the Company
      for the Notes, the Initial Shares and the Warrants

            1.3.25. "Registration Rights Agreement" means the registration
      rights agreement between the Investors and the Company in substantially
      the form of Exhibit D to this Agreement.

            1.3.26. "Registration Statement" means the registration statement
      under the 1933 Act to be filed with the Securities and Exchange Commission
      for the registration of the Shares pursuant to the Registration Rights
      Agreement.

                         SECURITIES PURCHASE AGREEMENT
                                     PAGE 4


            1.3.27. "Restated Articles" means the restated articles of
      organization in substantially the form of Exhibit E to this Agreement.

            1.3.28. "Securities" means the Notes, the shares of Series A
      Preferred Stock, the Warrants and the Shares.

            1.3.29. "SEC" means the Securities and Exchange Commission.

            1.3.30. "SEC Documents" means, at any given time, the Company's
      latest Form 10-K or Form 10-KSB and all Forms 10-Q or 10-QSB and 8-K and
      all proxy statements or information statements filed between the date the
      Form 10-K or Form 10-KSB was filed and the date as to which a
      determination is being made until such time as the Company no longer has
      an obligation to maintain the effectiveness of a Registration Statement as
      set forth in the Registration Rights Agreement.

            1.3.31. "Series A Preferred Stock" means the shares of Series A
      Preferred Stock having the rights, preferences and privileges and subject
      to the limitations set forth in the Certificate of Designation.

            1.3.32. "Shares" means, collectively, the (a) the Initial Shares and
      (b) the shares of Common Stock of the Company issued or issuable (i) upon
      conversion of the Notes or the Series A Preferred Stock or (ii) upon
      exercise of the Warrants.

            1.3.33. "Subsequent Financing" means any offer and sale of shares of
      the Company's preferred stock, par value $.0001 per share, or debt that,
      in either case, is initially convertible into shares of Common Stock or
      otherwise senior or superior to the Series A Preferred Stock.

            1.3.34. "Total Shares" means the Initial Shares plus the total
      number of shares of Common Stock as are issuable upon conversion of the
      Notes, such number to be determined as if the Notes are never converted
      into shares of Series A Preferred Stock.

            1.3.35. "Transaction Documents" means this Agreement, all Schedules
      and Exhibits attached hereto, the Certificate of Designation, the
      Warrants, the Registration Rights Agreement and all other documents and
      instruments to be executed and delivered by the parties in order to
      consummate the transactions contemplated hereby.

            1.3.36. "Warrants" means the Common Stock Purchase Warrants in
      substantially the form of Exhibit F-1, F-2 and F-3 to this Agreement.

            1.3.37. All references in this Agreement to "herein" or words of
      like effect, when referring to preamble, recitals, article and section
      numbers, schedules and exhibits shall refer to this Agreement unless
      otherwise stated.

                         SECURITIES PURCHASE AGREEMENT
                                     PAGE 5


                                   ARTICLE II

             SALE AND PURCHASE OF NOTE AND WARRANTS; PURCHASE PRICE

2.1.  Sale of Note and Issuance of Warrants.

            2.1.1. Upon the terms and subject to the conditions set forth
      herein, and in accordance with applicable law, the Company agrees to sell
      to the Investors, and the each Investor severally agrees to purchase from
      the Company, on the Closing Date the Notes, the Initial Shares and the
      Warrants as set forth after such Investor's name on Schedule A to this
      Agreement for that portion of the Purchase Price as is set forth on said
      Schedule A. The Purchase Price shall be paid by the Investors, severally,
      to the Company on the Closing Date by a wire transfer of the Purchase
      Price into escrow to be held by the escrow agent pursuant to the terms of
      the Escrow Agreement. The Company shall cause the Notes and the Warrants
      to be issued to the Investors upon the release of the Purchase Price to
      the Company by the escrow agent pursuant to the terms of the Escrow
      Agreement.

            2.1.2. As set forth more fully in the Notes:

                  (a) Principal and interest on the Notes shall be automatically
            converted into such number of shares of Series A Preferred Stock as
            is determined by dividing the principal amount of the Notes by the
            Conversion Price, as set forth in the Notes, which shall initially
            be sixty five cents ($.65) upon the filing by the Company of (i) the
            Restated Articles and (ii) the Certificate of Designation.

                  (b) If the Restated Articles and the Certificate of
            Designation shall not have been filed at the time the Notes is
            converted, the Notes shall be convertible into Common Stock at the
            Conversion Rate set forth in the Notes.

            2.1.3. Notwithstanding any other provision of this Agreement, except
      as expressly provided in the Notes, the Certificate of Designation or the
      Warrants, no Investor shall be entitled to convert the Notes or the Series
      A Preferred Stock into shares of Common Stock or to exercise the Warrants
      to the extent that such conversion or exercise would result in beneficial
      ownership by such Investor and its Affiliates of more than 4.9% of the
      then outstanding number of shares of Common Stock on such date. For the
      purposes of this Agreement beneficial ownership shall be determined in
      accordance with Section 13(d) of the Securities Exchange Act of 1934, as
      amended, and Regulation 13d-3 thereunder. The limitation set forth in this
      Section 2.1.3 is referred to as the "4.9% Limitation."

                         SECURITIES PURCHASE AGREEMENT
                                     PAGE 6


            2.1.4. Upon execution and delivery of this Agreement and the
      Company's receipt of the Purchase Price from the Escrow Agent pursuant to
      the terms of the Escrow Agreement, the Company shall issue to the Investor
      the Warrants to purchase the number of shares of Common Stock as is set
      forth in Schedule A to this Agreement at exercise prices as stated in the
      Warrants, all pursuant to the terms and conditions of the Warrants and
      subject to 4.9% Limitation.

2.2.  Purchase Price. The Purchase Price payable by each Investor shall be
      delivered by such Investor in the form of wire transfers in United States
      dollars from the Investor to the escrow agent pursuant to the Escrow
      Agreement on the Closing Date.

2.3.  Acquisition of Sinoenergy Stock. The Company shall have acquired all of
      the outstanding capital stock of Sinoenergy pursuant to the Exchange of
      Securities, and all of the stock and other equity interest of Sinogas
      shall be owned by Sinoenergy. No Person shall have any right, title or
      interest in, or any right or option to acquire, any shares of any class of
      capital stock of Sinoenergy or Sinogas.

2.4.  Ownership of Real Property. Sinogas has acquired, subject to formal
      government approval, title to real property (the "Real Property") acquired
      from Beijing Sanhuan Technology Development Co. Ltd., knows as Trycle.


                                  ARTICLE III

                     CLOSING DATE AND DELIVERIES AT CLOSING

3.1.  Closing Date. The Closing of the transactions contemplated by this
      Agreement shall be held at the offices of counsel for the Company, at 1:00
      P.M. local time, on the Closing Date or on such other date and time and at
      such other place as may be mutually agreed by the parties, including
      Closing by facsimile with originals to follow.

3.2.  Deliveries by the Company. In addition to and without limiting any other
      provision of this Agreement, the Company agrees to deliver, or cause to be
      delivered, to the escrow agent under the Escrow Agreement, the following:

            (a) At or prior to Closing, an executed Agreement with all exhibits
      and schedules attached hereto.

            (b) At the Closing, the executed Notes in the names of the
      Investors.

                         SECURITIES PURCHASE AGREEMENT
                                     PAGE 7


            (c) At the Closing, a stock certificate for the Initial Shares.

            (d) At or prior to the Closing, executed Warrants in the name of the
      Investors.

            (e) The executed Registration Rights Agreement.

            (f) Certifications in form and substance acceptable to the Company
      and the Investors from any and all brokers or agents involved in the
      transactions contemplated hereby as to the amount of commission or
      compensation payable to such broker or agent as a result of the
      consummation of the transactions contemplated hereby and from the Company
      or Investors, as appropriate, to the effect that reasonable reserves for
      any other commissions or compensation that may be claimed by any broker or
      agent have been set aside.

            (g) Evidence of approval of the board of directors of the Company of
      (i) the Transaction Documents and the transactions contemplated hereby and
      (ii) the Restated Articles, which shall be subject to stockholder
      approval.

            (h) Evidence of the agreement of the holders of not less than a
      majority of the share of Common Stock outstanding after the Exchange of
      Securities to approve the Restated Articles.

            (i) Evidence that the Company has complied with the provisions of
      Sections 6.10, 6.11 and 6.12 of this Agreement on or prior to the Closing
      Date.

            (j) Good standing certificates of the Company issued by the
      Secretary of State of Nevada.

            (k) An opinion from the Company's special counsel concerning the
      Transaction Documents and the transactions contemplated hereby in form and
      substance reasonably acceptable to Investors.

            (l) A letter from Sinogas' Chinese counsel concerning the Sinogas
      and the transactions contemplated hereby in form and substance reasonably
      acceptable to Investors.

            (m) The executed Escrow Agreement.

            (n) Copies of all executive employment agreements, all past and
      present financing documentation or other documentation where stock could
      potentially be issued or issued as payment, all past and present
      litigation documents and historical financials, not previously provided to
      Investors.

            (o) Such other documents or certificates as shall be reasonably
      requested by Barron on behalf of the Investor.

                         SECURITIES PURCHASE AGREEMENT
                                     PAGE 8


3.3.  Deliveries by Investors. In addition to and without limiting any other
      provision of this Agreement, the Investor agrees to deliver, or cause to
      be delivered, to the escrow agent under the Escrow Agreement, the
      following:

            (a) A deposit in the amount of the Purchase Price;

            (b) The executed Agreement with all Exhibits and Schedules attached
      hereto;

            (c) The executed Registration Rights Agreement;

            (d) The executed Escrow Agreement; and

            (e) Such other documents or certificates as shall be reasonably
      requested by the Company or its counsel.

In the event any document (other than the Notes and Warrants) provided to the
other party in Sections 3.2 and 3.3 herein are provided by facsimile, the party
shall forward an original document to the other party within seven (7) business
days.

3.4.  Further Assurances. The Company and the Investors shall, upon request, on
      or after the Closing Date, cooperate with each other (specifically, the
      Company shall cooperate with the Investors, and the Investors shall
      cooperate with the Company) by furnishing any additional information,
      executing and delivering any additional documents and/or other instruments
      and doing any and all such things as may be reasonably required by the
      parties or their counsel to consummate or otherwise implement the
      transactions contemplated by this Agreement.

3.5.  Waiver. The Investors may waive any of the requirements of Section 3.2 of
      this Agreement or any of its rights under the Escrow Agreement, and the
      Company at its discretion may waive any of its rights of Section 3.3 of
      this Agreement or any of its rights under the Escrow Agreement.

                                   ARTICLE IV

                  REPRESENTATIONS AND WARRANTIES OF THE COMPANY

      The Company represents and warrants to the Investors as of the date hereof
and as of Closing (which warranties and representations shall survive the
Closing regardless of what examinations, inspections, audits and other
investigations the Investors have heretofore made or may hereinafter make with
respect to such warranties and representations) as follows:

                         SECURITIES PURCHASE AGREEMENT
                                     PAGE 9


4.1.  Organization and Qualification.

            4.1.1. The Company is a corporation duly organized, validly existing
      and in good standing under the laws of the State of Nevada, and Sinogas is
      a Chinese equity joint venture, which is similar to a limited liability
      company, and each of the Company and Sinogas has the requisite corporate
      power and authority to own, lease and operate its properties and to carry
      on its business as it is now being conducted and is duly qualified to do
      business in any other jurisdiction by virtue of the nature of the
      businesses conducted by it or the ownership or leasing of its properties,
      except where the failure to be so qualified will not, when taken together
      with all other such failures, have a Material Adverse Effect on the
      business, operations, properties, assets, financial condition or results
      of operation of the Company and its subsidiaries taken as a whole. Sinogas
      is authorized to be a wholly-owned foreign enterprise, knows as a "WOFE,"
      under the laws of the People Republic of China, and the Exchange of
      Securities does not violate any provisions of Sinogas' organizational
      documents or the laws of the People's Republic of China.

            4.1.2. Sinogas is wholly-owned by Sinoenergy, and Sinoenergy is
      wholly-owned by the Company. Except for the stock in Sinoenergy which is
      owned by the Company and the stock of Sinogas which is owned by
      Sinoenergy, no person has any right, title or interest in any equity, debt
      or other securities of any kind of either Sinogas or Sinoenergy.

4.2.  Governing Documents. The complete and correct copies of the Company's
      Governing Documents, as in effect on the Closing Date, has been delivered
      to the Investors.

4.3.  Capitalization.

            4.3.1. The authorized and outstanding capital stock of the Company
      as of the date of this Agreement and as adjusted to reflect issuances
      pursuant to the Exchange of Securities and as contemplated by this
      Agreement is set forth in Schedule 4.3.1 to this Agreement. Schedule 4.3.1
      contains all shares and derivatives currently and potentially outstanding.
      The Company hereby represents that any and all shares and current
      potentially dilutive events have been included in Schedule 4.3.1,
      including shares issuable pursuant to employment agreements, acquisition,
      consulting agreements, debts, payments, financing or business
      relationships that could be paid in equity, derivatives or resulting in
      additional equity issuances.

            4.3.2. All outstanding shares of capital stock have been duly
      authorized and are validly issued, and are fully paid and non-assessable
      and free from preemptive rights. All shares of capital stock described
      above to be issued have been duly authorized and when issued, will be
      validly issued, fully paid and non-assessable and free from preemptive
      rights.

                         SECURITIES PURCHASE AGREEMENT
                                     PAGE 10


            4.3.3. Except pursuant to this Agreement and as set forth in
      Schedule 4.3.1 hereto, and as set forth in the Company's SEC Documents,
      filed with the SEC, as of the date hereof and as of the Closing Date,
      there are not now outstanding options, warrants, rights to subscribe for,
      calls or commitments of any character whatsoever relating to, or
      securities or rights convertible into or exchangeable for, shares of any
      class of capital stock of the Company, or agreements, understandings or
      arrangements to which the Company is a party, or by which the Company is
      or may be bound, to issue additional shares of its capital stock or
      options, warrants, scrip or rights to subscribe for, calls or commitment
      of any character whatsoever relating to, or securities or rights
      convertible into or exchangeable for, any shares of any class of its
      capital stock. The Company agrees to inform the Investors in writing of
      any additional warrants granted prior to the Closing Date.

            4.3.4. The Company on the Closing Date (i) will have full right,
      power, and authority to sell, assign, transfer, and deliver, by reason of
      record and beneficial ownership, to the Investors, the Notes, free and
      clear of all liens, charges, claims, options, pledges, restrictions, and
      encumbrances whatsoever; and (ii) upon conversion of the Notes or exercise
      of the Warrants, the Investors will acquire title to the Shares issuable
      upon such conversion or exercise, free and clear of all liens, charges,
      claims, options, pledges, restrictions, and encumbrances whatsoever,
      except as otherwise provided in this Agreement and except for any of the
      foregoing which results from actions or omissions on the part of the
      Investors.

4.4.  Authority.

            4.4.1. The Company has all requisite corporate power and authority
      to execute and deliver this Agreement, the Notes, the Initial Shares and
      the Warrants, to perform its obligations hereunder and thereunder and to
      consummate the transactions contemplated hereby and thereby. The execution
      and delivery of this Agreement by the Company and the consummation of the
      transactions contemplated hereby have been duly authorized by all
      necessary corporate action and no other corporate proceedings on the part
      of the Company is necessary to authorize this Agreement or to consummate
      the transactions contemplated hereby except as disclosed in this
      Agreement; provided, however, that stockholder approval is required for
      the Company to adopt the Restated Articles. This Agreement has been duly
      executed and delivered by the Company and constitutes the legal, valid and
      binding obligation of the Company, enforceable against the Company in
      accordance with its terms; provided, however, that no representation is
      made with respect to the ability of either Investor to convert the Notes
      or, following the filing of the Restated Articles and the Certificate of
      Designation, the Series A Preferred Stock or exercise any Warrant if and
      to the extent that the Conversion Price of the Notes or the Series A
      Preferred Stock, as defined in the Notes or the Certificate of
      Designation, or the number of Shares issuable upon exercise of the
      Warrants would result in the issuance of a number of shares of Common
      Stock which is greater than the amount by which the authorized Common
      Stock exceeds the sum of the outstanding Common Stock and the shares of
      Common Stock reserved for issuance pursuant to outstanding agreements and
      outstanding options, warrants, rights, convertible securities and other
      securities upon the exercise or conversion of which or pursuant to the
      terms of which additional shares of Common Stock may be issuable (the
      foregoing proviso being referred to as the "Authorized Stock Proviso").

                         SECURITIES PURCHASE AGREEMENT
                                     PAGE 11


            4.4.2. The Company's board of directors has adopted the Restated
      Articles and the Certificate of Designation, subject to stockholder
      approval of the Restated Articles, as required by the Nevada Act. Pursuant
      to NRS 78.320, the holders of shares of Common Stock issued pursuant to
      the Exchange of Securities have agreed to execute a consent of
      stockholders approving the Restated Articles, which consent shall be given
      twenty (20) days after the date the Company mails an information statement
      pursuant to Section 14(c) of the Exchange Act to its stockholders. The
      Company will file an information statement with the SEC as soon as
      practical after the Closing Date, but not later than ten days after the
      date the Form 10-KSB for the fiscal year ended March 31, 2006 is required
      to be filed with the SEC.

            4.4.3. The Initial Shares are, and shares of Series A Preferred
      Stock issuable upon conversion of the Notes and the Shares issuable upon
      conversion of the Notes and the Series A Preferred Stock and upon exercise
      of the Warrants will be, when so issued, duly and validly authorized and
      issued, fully paid and non-assessable and not issued in violation of any
      preemptive rights or rights of first refusal.

            4.4.4. Upon the filing with the Secretary of State of the State of
      Nevada of the Restated Articles and the Certificate of Designation, the
      shares of Series A Preferred Stock issued upon conversion of the Notes
      will be duly and validly authorized and issued, fully paid and
      non-assessable..

4.5.  No Conflict; Required Filings and Consents. The execution and delivery of
      this Agreement by the Company does not, and the performance by the Company
      of its obligations hereunder will not: (i) conflict with or violate the
      Company's Governing Documents or the governing instruments Sinogas; (ii)
      conflict with, breach or violate any federal, state, foreign or local law,
      statute, ordinance, rule, regulation, order, judgment or decree
      (collectively, "Laws") in effect as of the date of this Agreement and
      applicable to the Company or Sinoenergy or Sinogas; or (iii) result in any
      breach of, constitute a default (or an event that with notice or lapse of
      time or both would become a default) under, give to any other entity any
      right of termination, amendment, acceleration or cancellation of, require
      payment under, or result in the creation of a lien or encumbrance on any
      of the properties or assets of the Company or Sinoenergy or Sinogas
      pursuant to, any note, bond, mortgage, indenture, contract, agreement,
      lease, license, permit, franchise or other instrument or obligation to
      which the Company or Sinoenergy or Sinogas is a party or by the Company or
      Sinoenergy or Sinogas or any of their respective properties or assets is
      bound other than violations, conflicts, breaches, defaults, terminations,
      accelerations, creations of liens, or incumbency that would not, in the
      aggregate, have a Material Adverse Effect except to the extent that
      stockholder approval may be required as a result of the Authorized Stock
      Proviso, in which event, the Company will seek stockholder approval to an
      increase in the authorized Common Stock sufficient to enable the Company
      to be in compliance with this Section 4.5.

                         SECURITIES PURCHASE AGREEMENT
                                     PAGE 12


4.6.  Report and Financial Statements.

            4.6.1. The Company has delivered to the Investors the audited
      balance sheet of Sinogas as of December 31, 2005 and the audited
      statements of operations, stockholders equity and cash flows for the years
      ended December 31, 2005 and 2004, and the unaudited balance sheet as of
      March 31, 2006 and unaudited statements of operations and cash flows for
      the three months ended March 31, 2006 and 2005 and stockholders' equity
      for the three months ended March 31, 2006, in each cash including notes to
      the financial statements (collectively, the "Financial Statements"). Each
      of the balance sheets contained in such Financial Statements (including
      the related notes and schedules thereto) fairly presented the financial
      position of Sinogas, as of its date, and each of the statements of
      operations, stockholders' equity and cash flows in such Financial
      Statements (including any related notes and schedules thereto) fairly
      presents, changes in stockholders' equity and changes in cash flows, as
      the case may be, of Sinogas, for the periods to which they relate, in each
      case in accordance with GAAP, except in each case as may be noted therein,
      subject to normal year-end audit adjustments in the case of unaudited
      statements. The books and records of the Company have been, and are being,
      maintained in all material respects in accordance with GAAP and any other
      applicable legal and accounting requirements and reflect only actual
      transactions. Schwartz Levitsky Feldman LLP, who audited the audited
      financial statements, is independent within the meaning of the regulations
      of the SEC.

            4.6.2. The Company has provided the Investors with a copy of any
      management letter issued by Schwartz Levitsky Feldman LLP in connection
      with its audit of Sinogas's audited Financial Statements for 2004 if such
      firm issued a management letter. The Company has addressed, to the
      satisfaction of Schwartz Levitsky Feldman LLP any deficiencies reflected
      in the management letter.

4.7.  Compliance with Applicable Laws. The Company is not in violation of, or,
      to the knowledge of the Company, is under investigation with respect to or
      has been given notice or has been charged with the violation of any Laws,
      except for violations which individually or in the aggregate do not have a
      Material Adverse Effect.

4.8.  Brokers. No broker, finder or investment banker is entitled to any
      brokerage, finder's or other fee or Commission in connection with the
      transactions contemplated by this Agreement based upon arrangements made
      by or on behalf of the Company.

4.9.  SEC Documents. The Investors acknowledge that the Company is a publicly
      held company and has made available to the Investors true and complete
      copies of any requested SEC Documents. The Company has registered its
      Common Stock pursuant to Section 12(g) of the 1934 Act. The Company has
      not provided to the Investors any information that, according to
      applicable law, rule or regulation, should have been disclosed publicly
      prior to the date hereof by the Company, but which has not been so
      disclosed.

                         SECURITIES PURCHASE AGREEMENT
                                     PAGE 13


4.10. Litigation. To the knowledge of the Company, no litigation, claim, or
      other proceeding before any court or governmental agency is pending or to
      the knowledge of the Company, threatened against the Company, Sinoenergy
      or Sinogas, the prosecution or outcome of which, if adversely determined,
      is likely to have a Material Adverse Effect.

4.11. Exemption from Registration. Subject to the accuracy of the Investors'
      representations in Article V, except as required pursuant to the
      Registration Rights Agreement, the sale of the Securities by the Company
      to the Investors will not require registration under the 1933 Act. When
      validly converted in accordance with the terms of the Series A Preferred
      Stock, and upon exercise of the Warrants in accordance with their terms,
      the Shares underlying the Series A Preferred Stock and the Warrants will
      be duly and validly issued, fully paid, and non-assessable. The Company is
      issuing the Notes, the Initial Shares and, upon conversion of the Notes,
      the Series A Preferred Stock, and the Warrants in accordance with and in
      reliance upon the exemption from securities registration afforded, inter
      alia, by Rule 506 under Regulation D as promulgated by the SEC under the
      1933 Act, and/or Section 4(2) of the 1933 Act; provided, however, that
      certain filings and registrations may be required under state securities
      "blue sky" laws depending upon the residency of the Investors.

4.12. No General Solicitation or Advertising in Regard to this Transaction.
      Neither the Company nor any of its Affiliates nor, to the knowledge of the
      Company, any Person acting on its or their behalf (i) has conducted or
      will conduct any general solicitation (as that term is used in Rule 502(c)
      of Regulation D as promulgated by the SEC under the 1933 Act) or general
      advertising with respect to the sale of the Series A Preferred Stock or
      Warrants, or (ii) made any offers or sales of any security or solicited
      any offers to buy any security under any circumstances that would require
      registration of the Series A Preferred Stock or Warrants, under the 1933
      Act, except as required herein.

4.13. No Material Adverse Effect. Since September 30, 2005, no event or
      circumstance resulting in a Material Adverse Effect has occurred or exists
      with respect to Sinenergy or Sinogas. To the knowledge of the Company, no
      material supplier or customer has given notice, oral or written, that it
      intends to cease or reduce the volume of its business with Sinogas from
      historical levels.

4.14. Material Non-Public Information. The Company has not disclosed to either
      Investor any material non-public information that (i) if disclosed, would
      reasonably be expected to have a material effect on the price of the
      Common Stock or (ii) according to applicable law, rule or regulation,
      should have been disclosed publicly by the Company prior to the date
      hereof but which has not been so disclosed; provided, however, that the
      Company has disclosed to either Investor matters relating to the Company's
      acquisition of Sinogas and the financing of such acquisition.

                         SECURITIES PURCHASE AGREEMENT
                                     PAGE 14


4.15. Internal Controls And Procedures. To the knowledge of the Company, Sinogas
      maintains books and records and internal accounting controls which provide
      reasonable assurance that (I) all transactions to which Sinogas or any
      subsidiary is a party or by which its properties are bound have been
      executed with management's authorization; (ii) the recorded accounting of
      Sinogas' assets is compared with existing assets at regular intervals;
      (iii) access to Sinogas' assets is permitted only in accordance with
      management's authorization; and (iv) all transactions to which Sinogas or
      any subsidiary is a party or by which its properties are bound are
      recorded as necessary to permit preparation of the financial statements of
      the Company in accordance with standards of the Public Company Accounting
      Oversight Board; it being understood that neither the Company nor Sinogas
      has not conducted an internal controls audit and that no such audit has
      been required under applicable law.

4.16. Full Disclosure. No representation or warranty made by the Company in this
      Agreement and no certificate or document furnished or to be furnished to
      the Investors pursuant to this Agreement contains or will contain any
      untrue statement of a material fact, or omits or will omit to state a
      material fact necessary to make the statements contained herein or
      therein, taken as a whole, not misleading.


                                   ARTICLE V

                 REPRESENTATIONS AND WARRANTIES OF THE INVESTOR

The Investors, severally, represent and warrant to the Company that:

5.1.  Organization and Standing of the Investor.

            5.1.1. Such Investor was not formed for the purpose of investing
      solely in the Notes, Series A Preferred Stock, the Warrants or the shares
      of Common Stock which are the subject of this Agreement. Such Investor has
      the requisite power and authority to enter into and perform this Agreement
      and to purchase the securities being sold to it hereunder. The execution,
      delivery and performance of this Agreement by such Investor and the
      consummation by such Investor of the transactions contemplated hereby have
      been duly authorized by all necessary partnership action where
      appropriate.

            5.1.2. The state in which any offer to purchase Preferred Stock
      hereunder was made or accepted by such Investor is the state shown as such
      Investor's address.

                         SECURITIES PURCHASE AGREEMENT
                                     PAGE 15


5.2.  Authorization and Power. This Agreement and the Registration Rights
      Agreement have been duly executed and delivered by such Investor and at
      the Closing shall constitute valid and binding obligations of such
      Investor enforceable against such Investor in accordance with their terms,
      except as such enforceability may be limited by applicable bankruptcy,
      insolvency, reorganization, moratorium, liquidation, conservatorship,
      receivership or similar laws relating to, or affecting generally the
      enforcement of, creditors' rights and remedies or by other equitable
      principles of general application.

5.3.  No Conflicts. The execution, delivery and performance of this Agreement
      and the consummation by such Investor of the transactions contemplated
      hereby or relating hereto do not and will not (i) result in a violation of
      such Investor's charter documents or bylaws where appropriate or (ii)
      conflict with, or constitute a default (or an event which with notice or
      lapse of time or both would become a default) under, or give to others any
      rights of termination, amendment, acceleration or cancellation of any
      agreement, indenture or instrument to which such Investor is a party, or
      result in a violation of any law, rule, or regulation, or any order,
      judgment or decree of any court or governmental agency applicable to such
      Investor or its properties (except for such conflicts, defaults and
      violations as would not, individually or in the aggregate, have a Material
      Adverse Effect on such Investor). The Investor is not required to obtain
      any consent, authorization or order of, or make any filing or registration
      with, any court or governmental agency in order for it to execute, deliver
      or perform any of such Investor's obligations under this Agreement or to
      purchase the securities from the Company in accordance with the terms
      hereof, provided that for purposes of the representation made in this
      sentence, such Investor is assuming and relying upon the accuracy of the
      relevant representations and agreements of the Company herein.

5.4.  Financial Risks. Such Investor acknowledges that such Investor is able to
      bear the financial risks associated with an investment in the securities
      being purchased by such Investor from the Company and that it has been
      given full access to such records of the Company and the subsidiaries and
      to the officers of the Company and the subsidiaries as it has deemed
      necessary or appropriate to conduct its due diligence investigation. The
      Investor is capable of evaluating the risks and merits of an investment in
      the securities being purchased by such Investor from the Company by virtue
      of its experience as an investor and its knowledge, experience, and
      sophistication in financial and business matters and such Investor is
      capable of bearing the entire loss of its investment in the securities
      being purchased by such Investor from the Company.

                         SECURITIES PURCHASE AGREEMENT
                                     PAGE 16


5.5.  Accredited Investor. The Investor is (i) an "accredited investor" as that
      term is defined in Rule 501 of Regulation D promulgated under the 1933 Act
      by reason of Rule 501(a)(3) and (6), (ii) experienced in making
      investments of the kind described in this Agreement and the related
      documents, (iii) able, by reason of the business and financial experience
      of its officers (if an entity) and professional advisors (who are not
      affiliated with or compensated in any way by the Company or any of its
      affiliates or selling agents), to protect its own interests in connection
      with the transactions described in this Agreement, and the related
      documents, and (iv) able to afford the entire loss of its investment in
      the securities being purchased by such Investor from the Company. The
      Investor is acquiring the Securities for investment and not with a view to
      the sale or distribution thereof and understands that such Securities are
      restricted securities, as defined in the 1933 Act, and may not be sold or
      otherwise distributed except pursuant to an effective registration
      statement or an exemption from the registration requirements of the 1933
      Act and that the certificates for such securities shares and Warrants will
      bear an investment legend.

5.6.  Brokers. No broker, finder or investment banker is entitled to any
      brokerage, finder's or other fee or commission in connection with the
      transactions contemplated by this Agreement based upon arrangements made
      by or on behalf of such Investor.

5.7.  Knowledge of Company. The Investor and its advisors, if any, have been,
      upon request, furnished with all materials relating to the business,
      finances and operations of the Company and materials relating to the offer
      and sale of the securities being purchased by such Investor from the
      Company. The Investor and its advisors, if any, have been afforded the
      opportunity to ask questions of the Company and have received complete and
      satisfactory answers to any such inquiries.

5.8.  Risk Factors. The Investor understands that the investment by such
      Investor in the Securities being purchased by such Investor from the
      Company involves a high degree of risk. The Investor understands that no
      United States federal or state agency or any other government or
      governmental agency has passed on or made any recommendation or
      endorsement of the securities being purchased by such Investor from the
      Company. The Investor warrants that it is able to bear the complete loss
      of its investment in the securities being purchased by it from the
      Company. In acquiring the Securities, such Investor is not relying upon
      any projections of the future financial condition, results of operations
      or cash flows relating to the Company. The Investor acknowledges and
      agrees that (a) it has had the opportunity to obtain, and it has reviewed
      and discussed with the Company, to the extent that it deems necessary,
      information concerning the Company, including risks relating to the
      Company, Sinogas and their respective financial statements, and that (b)
      in entering into and performing this Agreement, such Investor has not
      relied on any oral representations made by the Company or any of its
      agents, representatives or advisors.

5.9.  Full Disclosure. No representation or warranty made by such Investor in
      this Agreement and no certificate or document furnished or to be furnished
      to the Company pursuant to this Agreement contains or will contain any
      untrue statement of a material fact, or omits or will omit to state a
      material fact necessary to make the statements contained herein or therein
      not misleading. Except as set forth or referred to in this Agreement, (a)
      such Investor does not have any agreement or understanding with any person
      relating to acquiring, holding, voting or disposing of any equity
      securities of the Company. and (b) during the past five years there has
      not occurred any event listed in Item 401(f) of Regulation S-K or any
      investigation relating to any such event with respect to such Investor or
      any of its managing partners.

                         SECURITIES PURCHASE AGREEMENT
                                     PAGE 17


                                   ARTICLE VI

                            COVENANTS OF THE COMPANY

6.1.  Registration Rights. The Company shall cause the Registration Rights
      Agreement to remain in full force and effect and shall comply in all
      material respects with the terms thereof.

6.2.  Reservation of Common Stock. As of the date hereof, the Company has
      reserved and the Company shall continue to reserve and keep available at
      all times, free of preemptive rights, shares of Common Stock for the
      purpose of enabling the Company to issue the Shares underlying the Notes
      or the Series A Preferred Stock, as the case may be, and the Warrants;
      provided, however, that if, as a result of the Authorized Stock Proviso,
      there are not sufficient shares reserved as required in this Section 6.2,
      the Company shall, within thirty (30) days after the Company becomes aware
      of such deficiency, prepare and file with the Commission a proxy statement
      pursuant to which the Company will seek stockholder approval for an
      increase in the authorized Common Stock sufficient to enable the Company
      to be in compliance with this Section 6.2. Each Investor agrees to vote in
      favor of such proposal.

6.3.  Compliance with Laws. The Company hereby agrees to comply in all material
      respects with the Company's reporting, filing and other obligations under
      the federal securities laws.

6.4.  Exchange Act Registration. The Company will use its best efforts to comply
      in all respects with its reporting and filing obligations under the 1934
      Act, and will not take any action or file any document (whether or not
      permitted by the 1934 Act or the rules thereunder) to terminate or suspend
      any such registration or to terminate or suspend its reporting and filing
      obligations under the 1934 until the Investors have disposed of all of
      their Shares.

6.5.  Corporate Existence; Conflicting Agreements. The Company will take all
      steps necessary to preserve and continue the corporate existence of the
      Company. The Company shall not enter into any agreement, the terms of
      which agreement would restrict or impair the right or ability of the
      Company to perform any of its obligations under this Agreement or any of
      the other agreements attached as exhibits hereto. Notwithstanding the
      foregoing, nothing in this Agreement shall preclude the Company from
      re-incorporating in Delaware provided that (a) the rights of such Investor
      under the Notes are not impaired in any manner and (b) the terms of the
      Certificate of Designation shall be reflected in a certificate of
      designation filed pursuant to the Delaware General Corporation Law which
      is the same as the Certificate of Designation except for changes necessary
      to conform to Delaware law, none of which shall impair the rights of the
      holders of the Series A Preferred Stock. In the event of such
      reincorporation, all references in this Agreement and the Notes to the
      Certificate of Designation shall relate to the certificate of
      incorporation of the Delaware corporation and the certificate of
      designation filed pursuant thereto.

                         SECURITIES PURCHASE AGREEMENT
                                     PAGE 18


6.6.  Series A Preferred Stock. Until the earliest of (a) three years from the
      Closing or (b) such date as the Investor shall have converted the Notes or
      the Series A Preferred Stock into not less than 90% of the Total Shares
      sold the underlying Shares or (c) such date as the Investor shall have
      transferred the Notes or the Series A Preferred Stock which are
      convertible into an aggregate of not less than 90% of the Total Shares,
      the Company will not issue any preferred stock of with the exception of
      Series A Preferred Stock issued to the Investor as provided in this
      Agreement and the Registration Rights Agreement.

6.7.  Convertible Debt. On or prior to the Closing Date, the Company will cause
      to be cancelled all convertible debt in the Company. Until the earliest of
      (a) three years from the Closing or (b) such date as the Investor shall
      have converted the Notes or the Series A Preferred Stock into not less
      than 90% of the Total Shares sold the underlying Shares or (c) such date
      as the Investor shall have transferred the Notes or the Series A Preferred
      Stock which are convertible into an aggregate of not less than 90% of the
      Total Shares, the Company will not issue any convertible debt.

6.8.  Debt Limitation. The Company agrees that, for two years after Closing,
      neither it nor its consolidated subsidiaries, shall enter into any new
      borrowings to the extent that the principal amount of such borrowings
      outstanding at the end of a calendar quarter is more than three times the
      sum of the EBITDA from continuing operations over the four quarters ending
      on such date.

6.9.  Reset Equity Deals. On or prior to the Closing Date, the Company will
      cause to be cancelled any and all reset features related to any shares
      outstanding that could result in additional shares being issued. For a
      period of three years from the Closing the Company will not enter into any
      transactions that have any reset features that could result in additional
      shares being issued. For purposes of this Section 6.9, a reset provision
      for a convertible security or derivative security shall mean a provision
      (a) whereby the issuance of securities at a lower price or having a lower
      conversion or exercise price will result in the conversion or exercise
      price of the security being reduced to the lower price or lower conversion
      or exercise price or more shares being issued, as the case may be, or (b)
      which provide that the conversion or exercise price is based on the market
      price at the time of conversion or exercise or (c) any other device which
      results in an adjustment to the exercise price or conversion price of the
      securities other than stock dividends, stock splits, stock distributions,
      combination of shares, reverse splits, and other recapitalizations, as
      long as they effect all stockholders appropriately.

                         SECURITIES PURCHASE AGREEMENT
                                     PAGE 19


6.10. Independent Directors.

            6.10.1. The Company shall have caused the appointment of the
      majority of the board of directors to be independent directors, as defined
      by the rules of the Nasdaq Stock Market, not later than the Closing Date.

            6.10.2. If, at any time subsequent to the Closing Date until the
      earlier of (a) three years from the Closing or (b) such date as the
      Investors shall have converted not less than 90% of the Convertible
      Securities and sold the underlying Shares or (c) such date as the
      Investors shall have transferred not less than 90% of the Convertible
      Securities or (d) such date as the total number or principal amount of
      Convertible Securities which the Investors shall have either transferred
      or converted and sold the underlying Shares shall represent not less than
      90% of Shares issuable upon conversion of the Convertible Securities
      issued to the Investors, the board of directors shall not be composed of a
      majority of independent directors:

                  6.10.2.1. for a reason other than for an Excused Reason, the
            Company shall have 60 days to take such steps as are necessary so
            that a majority of the Company's directors are independent
            directors, and

                  6.10.2.2. for an Excused Reason, the Company shall have 75
            days from the date that the Company becomes aware of the event (or
            the last event if there are more than one such event) giving rise to
            the Excused Reason, to take such steps as are necessary so that a
            majority of the Company's directors are independent directors.

            6.10.3. The term "Excused Reason" shall mean the death or
      resignation of an independent director or the occurrence of an event
      whereby an independent director ceases to be independent.

            6.10.4. If, during the period referred to in Section 6.10.2 of this
      Agreement, the Company shall have failed to have a board of directors
      composed of a majority of independent directors after the date by which
      such situation was to have been cured pursuant to Section 6.10.2.1 or
      Section 6.10.2.2 of this Agreement, whichever shall apply, the Company
      shall pay to the Investors, as liquidated damages and not as a penalty, an
      amount equal to twelve percent (12%) per annum of the Purchase Price of
      the then outstanding shares of Series A Preferred Stock or principal
      amount of the Notes, as the case may be, payable monthly in cash or Series
      A Preferred Stock at the option of the Investors, based on the number of
      days that such condition exists beyond the applicable grace period;
      provided, however, that if the Restated Articles shall not have been
      filed, the Company may issue a Note in lieu of shares of Series A
      Preferred Stock pursuant to this Section 6.10 and Section 6.11 of this
      Agreement. The parties agree that the only damages payable for a violation
      of such provisions shall be such liquidated damages. Nothing shall
      preclude the Investors from pursuing or obtaining specific performance or
      other equitable relief with respect to this Agreement. The parties hereto
      agree that the liquidated damages provided for in this Section 6.10.4
      constitute a reasonable estimate of the damages that may be incurred by
      the Investors by reason of the failure of the Company to have a majority
      of directors as independent directors.

                         SECURITIES PURCHASE AGREEMENT
                                     PAGE 20


            6.10.5. In no event shall the total payments made pursuant to this
      Section 6.10 and Section 6.11, whether in cash or Series A Preferred Stock
      exceed in the aggregate twelve percent (12%) of the Purchase Price of the
      shares of Series A Preferred Stock or principal amount of the Notes, as
      the case may be, that are outstanding as of the date on which a
      computation is being made.

6.11. Independent Directors on Audit and Compensation Committees. No later than
      the Closing Date, the Company will have an audit committee comprised
      solely of not less than three independent directors and a compensation
      committee comprised of not less than three directors, a majority of whom
      are independent directors. If at any time after the subsequent to the
      Closing Date, independent directors do not comprise all of the members of
      the audit committee and a majority of the members of the compensation
      committee within the grace periods provided in Section 6.10, the Company
      shall pay to the Investors, as liquidated damages and not as a penalty, an
      amount equal to twelve percent (12%) per annum of the Purchase Price of
      the then outstanding Series A Preferred Stock or principal amount of the
      Notes, as the case may be, payable monthly in cash or Series A Preferred
      Stock at the option of the Investors, such payment shall be based on the
      number of days that such condition exists. The parties agree that the only
      damages payable for a violation of the terms of this Agreement with
      respect to which liquidated damages are expressly provided shall be such
      liquidated damages. Nothing shall preclude the Investors from pursuing
      other remedies or obtaining specific performance or other equitable relief
      with respect to this Agreement. Notwithstanding the foregoing, no
      liquidated damages shall be payable pursuant to this Section 6.11 during
      any period for which liquidated damages are payable pursuant to Section
      6.10.

6.12. Chief Financial Officer. Not later than the Closing Date, the Company will
      have elected a chief financial officer who is familiar with both the
      conduct of business in China and the SEC's rules and regulations relating
      to accounting, financial statements and accounting controls.

6.13. Use of Proceeds. The Company will use the net proceeds from the sale of
      the Notes, the Initial Shares and the Warrants (excluding amounts paid by
      the Company for legal and administrative fees and other expenses of the
      transaction) for working capital.

6.14. Right of First Refusal

            6.14.1. In the event that the Company seeks to raise additional
      funds through a private placement of its securities (a "Proposed
      Financing"), other than Exempt Issuances, each Investor shall have the
      right to participate in any subsequent funding by the Company of the
      offering price on a pro rata basis, based on the percentage that (a) the
      number of such Investor's Total Shares, without regard to the 4.9%
      Limitation, bears to (b) the total number of shares of Common Stock
      outstanding plus the number of Shares issuable upon conversion of the
      Notes or Series A Preferred Stock, as the case may be, and any other
      series of convertible preferred stock or debt securities, without regard
      to the 4.9% Limitations any other limitations on exercise such other
      convertible preferred stock or debt securities. This Section 6.14 shall
      apply to each such offering based on the total purchase price of the
      securities being offered by the Company.

                         SECURITIES PURCHASE AGREEMENT
                                     PAGE 21


            6.14.2. The terms on which the Investors shall purchase securities
      pursuant to Proposed Financing shall be the same as such securities are
      purchased by other investors. The Company shall give the Investors the
      opportunity to participate in the offering by giving the Investors not
      less than ten (10) days notice setting forth the terms of the Proposed
      Financing. In the event that the terms of the Proposed Financing are
      changed in a manner which is more favorable to the potential investor, the
      Company shall provide the Investors, at the same time as the notice is
      provided to the other potential investors, with a new ten (10) day notice
      setting forth the revised terms that are provided to the other potential
      investors.

            6.14.3. In the event that the Investors does not exercise its right
      to participate in the Proposed Financing within the time limits set forth
      in Section 6.14.2 of this Agreement, the Company may sell the securities
      in the Proposed Financing at a price and on terms which are no more
      favorable to the investors than the terms provided to the Investors. If
      the Company subsequently changes the price or terms so that the price is
      more favorable to the investors or so the terms are more favorable to the
      investors, the Company shall provide the Investors with the opportunity to
      purchase the securities on the revised terms in the manner set forth in
      Section 6.14.2 of this Agreement.

6.15. Price Adjustment. From the date hereof until such time as the Investors
      holds no Securities, except for Exempt Issuances, as to which this Section
      6.15 does not apply, if the Company closes on the sale or issuance of
      Common Stock at a price, or warrants, options, convertible debt or equity
      securities with a exercise price per share or exercise price per share
      which is less than the Conversion Price then in effect (such lower sales
      price, conversion or exercise price, as the case may be, being referred to
      as the "Lower Price"), the Conversion Price in effect from and after the
      date of such transaction shall be reduced to the Lower Price. For purpose
      of determining the exercise price of warrants issued by the Company, the
      price, if any, paid per share for the warrants shall be added to the
      exercise price of the warrants. A similar provision shall be included in
      the Warrants; provided, however, that the adjustment for the Warrants with
      exercise prices of $1.20 and $1.75 per share shall have a formula
      reduction.

                         SECURITIES PURCHASE AGREEMENT
                                     PAGE 22


6.16. Price Adjustments Based on Pre-Tax Income Per Share.

            6.16.1. The Certificate of Designation shall contain the following
      provisions, and similar provisions shall be included in the Warrants.

            6.16.2. In the event the Company's consolidated Pre-Tax Income for
      the year ended December 31, 2006 is less than $.212 per share on a
      fully-diluted basis, then the Conversion Price shall be reduced by the
      percentage shortfall, up to a maximum of 40%. Thus, if Net Income for the
      year ended December 31, 2006 is $.1272 per share on a fully-diluted basis,
      the Conversion Price shall be reduced by 40%. Such reduction shall be made
      at the time the Company files its Form 10-KSB for the year ended December
      31, 2006, and shall apply to the Notes or all shares of the Series A
      Preferred Stock, as the case may be, which are outstanding on the date the
      Form 10-KSB is filed, or, if not filed on time, on the date that filing
      was required.

            6.16.3. In the event the Company's consolidated Pre-Tax Income for
      the year ended December 31, 2007 is less than $.353 per share on a
      fully-diluted basis, then the Conversion Price shall be reduced by the
      percentage shortfall, up to a maximum of 40%. Thus, if Pre-Tax Income for
      the year ended December 31, 2008 is $.2118 per share on a fully-diluted
      basis, the Conversion Price shall be reduced by 40%. Such reduction shall
      be made at the time the Company files its Form 10-KSB for the year ended
      December 31, 2007, and shall apply to the Notes or all shares of the
      Series A Preferred Stock, as the case may be, which are outstanding on the
      date the Form 10-KSB is filed, or, if not filed on time, on the date that
      filing was required.

            6.16.4. For purpose of determining Net Income Per Share and Pre-Tax
      Income Per Share on a fully-diluted basis, all shares of Common Stock
      issuable upon conversion of convertible securities and upon exercise of
      warrants and options shall be deemed to be outstanding, regardless of
      whether (i) such shares are treated as outstanding for determining diluted
      earnings per share under GAAP, (ii) such securities are "in the money," or
      (iii) such shares may be issued as a result of the 4.9% Limitation.

6.17. Insider Selling. The earliest any Restricted Stockholders can start
      selling their shares of Common Stock in the public market shall be
      eighteen months from the Closing Date. Restricted Stockholders shall
      include all persons who are officers and directors of the Company and all
      present holders of equity interests in Sinogas. Andrew Barron Worden and
      the Investors shall not be considered Restricted Stockholders. The
      restrictions in this Section 6.17 shall not apply to shares issued
      pursuant to a stock option or long-term incentive plans which may be
      approved by the Compensation Committee provided that such committee is
      comprises of a majority of independent directors. The Company may include
      in the registration statement filed pursuant to the Registration Rights
      Agreement all of the shares of Common Stock which are outstanding
      immediately prior to the Closing, none of which shall be owned by
      Affiliates of the Company, Sinoenergy or Sinogas. Notwithstanding the
      forgoing, Eastpride Capital Limited can sell fifty percent (50%) of its
      shares of Common Stock in the public market during the one (1) year period
      commencing twelve (12) months from the Closing Date and the remaining
      shares of Common Stock commencing twenty four (24) months from the Closing
      Date.

                         SECURITIES PURCHASE AGREEMENT
                                     PAGE 23


6.18. Employment and Consulting Contracts. For three years after the Closing,
      Company must have a unanimous approval from the Compensation Committee of
      the Board of Directors having reached a conclusion that any awards other
      than salary are usual, appropriate and reasonable for any officer,
      director or consultants whose compensation is more than $100,000 per
      annum. This Section 6.18 does not apply to attorneys, accountants and
      other persons who provide professional services to the Company.

6.19. Subsequent Equity Sales. From the date hereof until such time as the
      Investors hold no more than 5% of the Shares (determined as if the Series
      A Preferred Stock were fully converted and the Warrants fully exercised),
      the Company shall be prohibited from effecting or entering into an
      agreement to effect any Subsequent Financing involving a "Variable Rate
      Transaction" or an "MFN Transaction" (each as defined below). The term
      "Variable Rate Transaction" shall mean a transaction in which the Company
      issues or sells (i) any debt or equity securities that are convertible
      into, exchangeable or exercisable for, or include the right to receive
      additional shares of Common Stock either (A) at a conversion, exercise or
      exchange rate or other price that is based upon and/or varies with the
      trading prices of or quotations for the shares of Common Stock at any time
      after the initial issuance of such debt or equity securities, or (B) with
      a conversion, exercise or exchange price that is subject to being reset at
      some future date after the initial issuance of such debt or equity
      security or upon the occurrence of specified or contingent events directly
      or indirectly related to the business of the Company or the market for the
      Common Stock. The term "MFN Transaction" shall mean a transaction in which
      the Company issues or sells any securities in a capital raising
      transaction or series of related transactions which grants to an investor
      the right to receive additional shares based upon future transactions of
      the Company on terms which are more favorable to the Investors than the
      terms initially provided to the investor in its initial securities
      purchase agreement with the Company. The Investors shall be entitled to
      obtain injunctive relief against the Company to preclude any such
      issuance, which remedy shall be in addition to any right to collect
      damages. Notwithstanding the foregoing, this Section 6.19 shall not apply
      in respect of an Exempt Issuance, except that no Variable Rate Transaction
      or MFN Transaction shall be an Exempt Issuance.

6.20. Approval of Restated Articles. The Company shall adopt the Restated
      Articles and the file the Restated Articles and the Certificate of
      Designation not later than one hundred twenty (120) from the Closing Date.

6.21. Stock Splits. All forward and reverse stock splits shall effect all equity
      and derivative holders proportionately.

                         SECURITIES PURCHASE AGREEMENT
                                     PAGE 24


6.22. Payment of Due Diligence Expenses. At Closing the Escrow Agent shall
      disperse to the Barron Fifty Thousand Dollars ($50,000.00) for due
      diligence, legal and any other expenses which the Investors may incur in
      connection with this Agreement.

6.23. Title to Real Property. The Company shall, and shall cause Sinogas to,
      obtain all necessary government approvals to the transfer of the Real
      Property into the name of Sinogas.

6.24. Restriction on Certain Payments. The Company has advised the Investors
      that Sinogas has incurred liabilities of RMB 56,000,000, in connection
      with the purchase of the Real Property, of which approximately RMB
      26,000,000 (the "Restricted Amount") is owed to officers, directors or
      other affiliates of the Company, including Beijing Sanhuan Technology
      Development Co. Ltd. The RMB 30,000,000 which may be paid as hereinafter
      provided is referred to as the "Payable Amount." The Company shall not,
      and shall cause Sinogas not to, pay any of Restricted Amount to Sinogas'
      officers, directors or other affiliates until the earlier of (i) such time
      as the Real Property is sold, and then only from the net proceeds of sale
      or (ii) such time as all of the Shares shall have been sold in the public
      market. The Company shall not, and shall cause Sinogas not to, make any
      payment in respect to Payable Amount except as follows: Consolidated net
      income for the Company shall be determined on a quarterly basis, in
      accordance with GAAP as reflected in the Company's filings with the SEC.
      For each quarter, the amount payable with respect to the Payable Amount
      shall not exceed fifty percent (50%) of the Company's net income and shall
      be payable not earlier than the second business day after the applicable
      quarterly or annual report is filed with the SEC. Notwithstanding the
      foregoing, in no event shall any payment may made on account of the
      purchase of the Real Property prior to the date that Sinogas and the
      seller shall have received all government approvals necessary for the
      transfer of the Real Property to Sinogas.


                                  ARTICLE VII

                           COVENANTS OF THE INVESTORS

7.1.  Compliance with Law. Each Investor covenants that its trading activities
      with respect to shares of the Company's Common Stock will be in compliance
      with all applicable state and federal securities laws, rules and
      regulations and rules and regulations of any public market on which the
      Company's Common Stock is listed.

7.2.  Transfer Restrictions. Each Investor acknowledges that (1) the Notes, the
      Initial Shares and Warrants and shares of Series A Preferred Stock and
      Common Stock issuable upon conversion of the Notes and Series A Preferred
      Stock or upon exercise of the Warrants have not been registered under the
      1933 Act, and may not be transferred unless (A) subsequently registered
      thereunder or (B) the Investor shall have delivered to the Company an
      opinion of counsel, which counsel and opinion shall be reasonably
      satisfactory to the Company, to the effect that the Securities to be sold
      or transferred may be sold or transferred pursuant to an exemption from
      such registration; and (2) any sale of the Securities made in reliance on
      Rule 144 promulgated under the 1933 Act may be made only in accordance
      with the terms of said Rule, to the extent that such Rule is applicable.

                         SECURITIES PURCHASE AGREEMENT
                                     PAGE 25


7.3.  Restrictive Legend. Each Investor acknowledges and agrees that the
      Securities and the Shares shall bear a restrictive legend and a
      stop-transfer order may be placed against transfer of any such Securities
      except that the requirement for a restrictive legend shall not apply to
      Shares sold pursuant to a current and effective registration statement or
      a sale pursuant Rule 144 or any successor rule:

7.4.  Restated Articles. Each Investor hereby agrees to vote any shares of
      capital stock that the Investor may own directly or beneficially, for the
      adoption of the Restated Articles.

7.5.  Limitation on Amendment. No Investor shall take any action to modify the
      4.9% Limitation in this Agreement, the Notes, the Certificate of
      Designation or the Warrants.


                                  ARTICLE VIII

                CONDITIONS PRECEDENT TO THE COMPANY'S OBLIGATIONS

      The obligation of the Company to consummate the transactions contemplated
hereby shall be subject to the fulfillment, on or prior to Closing Date, of the
following conditions:

8.1.  No Termination. This Agreement shall not have been terminated pursuant to
      Article X hereof.

8.2.  Representations True and Correct. The representations and warranties of
      the Investor contained in this Agreement shall be true and correct in all
      material respects on and as of the Closing Date with the same force and
      effect as if made on as of the Closing Date.

8.3.  Compliance with Covenants. The Investor shall have performed and complied
      in all material respects with all covenants, agreements, and conditions
      required by this Agreement to be performed or complied with by it prior to
      or at the Closing Date.

8.4.  No Adverse Proceedings. On the Closing Date, no action or proceeding shall
      be pending by any public authority or individual or entity before any
      court or administrative body to restrain, enjoin, or otherwise prevent the
      consummation of this Agreement or the transactions contemplated hereby or
      to recover any damages or obtain other relief as a result of the
      transactions proposed hereby.

                         SECURITIES PURCHASE AGREEMENT
                                     PAGE 26


                                   ARTICLE IX

                 CONDITIONS PRECEDENT TO INVESTORS' OBLIGATIONS

      The obligation of the Investors to consummate the transactions
contemplated hereby shall be subject to the fulfillment, on or prior to Closing
Date unless specified otherwise, of the following conditions:

9.1.  No Termination. This Agreement shall not have been terminated pursuant to
      Article X hereof.

9.2.  Representations True and Correct. The representations and warranties of
      the Company contained in this Agreement shall be true and correct in all
      material respects on and as of the Closing Date with the same force and
      effect as if made on as of the Closing Date.

9.3.  Compliance with Covenants. The Company shall have performed and complied
      in all material respects with all covenants, agreements, and conditions
      required by this Agreement to be performed or complied with by it prior to
      or at the Closing Date.

9.4.  No Adverse Proceedings. On the Closing Date, no action or proceeding shall
      be pending by any public authority or individual or entity before any
      court or administrative body to restrain, enjoin, or otherwise prevent the
      consummation of this Agreement or the transactions contemplated hereby or
      to recover any damages or obtain other relief as a result of the
      transactions proposed hereby.

9.5.  Exchange of Securities Completed. The Exchange of Securities shall have
      been completed on or prior to the Closing Date, and the Company shall be
      the sole equity owner of Sinoenergy and Sinoenergy shall be the sole
      equity owner of Sinogas.

                                   ARTICLE X

                        TERMINATION, AMENDMENT AND WAIVER

10.1. Termination. This Agreement may be terminated at any time prior to the
      Closing Date

            10.1.1. by mutual written consent of the Investors and the Company;

            10.1.2. by the Company upon a material breach of any representation,
      warranty, covenant or agreement on the part of the Investors set forth in
      this Agreement, or by the Investors upon a material breach of any
      representation, warranty, covenant or agreement on the part of the Company
      set forth in this Agreement, or by either party if (a) the representations
      or warranties of the other party, taken together, shall fail to be true
      and correct in all material respects or (b) if the conditions to closing
      set forth in Article VIII or Article IX of this Agreement set forth in
      Article VIII or Article IX hereof shall not be satisfied, and such breach
      or failure shall, if capable of cure, not have been cured within five (5)
      business days after receipt by the party in breach of a notice from the
      non-breaching party setting forth in detail the nature of such breach.

                         SECURITIES PURCHASE AGREEMENT
                                     PAGE 27


10.2. Effect of Termination. Except as otherwise provided herein, in the event
      of the termination of this Agreement pursuant to Section 10.1 hereof,
      there shall be no liability on the part of the Company or the Investors or
      any of their respective officers, directors, agents or other
      representatives and all rights and obligations of any party hereto shall
      cease.

10.3. Amendment. This Agreement may be amended by the parties hereto any time
      prior to the Closing Date by an instrument in writing signed by the
      parties hereto; provided, however that the 4.9% Limitation may not be
      amended or waived.

10.4. Waiver. At any time prior to the Closing Date, the Company or the
      Investors, as appropriate, may: (a) extend the time for the performance of
      any of the obligations or other acts of other party or; (b) waive any
      inaccuracies in the representations and warranties contained herein or in
      any document delivered pursuant hereto which have been made to it or them;
      or (c) waive compliance with any of the agreements or conditions contained
      herein for its or their benefit other than the 4.9% Limitation which may
      not be waived. Any such extension or waiver shall be valid only if set
      forth in an instrument in writing signed by the party or parties to be
      bound hereby.


                                   ARTICLE XI

                               GENERAL PROVISIONS

11.1. Transaction Costs. Except as otherwise provided herein, each of the
      parties shall pay all of his or its costs and expenses (including attorney
      fees and other legal costs and expenses and accountants' fees and other
      accounting costs and expenses) incurred by that party in connection with
      this Agreement; provided, the Company shall pay the Investors for its
      expenses as provided in Section 6.22.

11.2. Indemnification. The Investor agrees to indemnify, defend and hold the
      Company (following the Closing Date) and its officers and directors
      harmless against and in respect of any and all claims, demands, losses,
      costs, expenses, obligations, liabilities or damages, including interest,
      penalties and reasonable attorney's fees, that it shall incur or suffer,
      which arise out of or result from any breach of this Agreement by the
      Investors or failure by the Investors to perform with respect to the
      representations, warranties or covenants contained in this Agreement or in
      any exhibit or other instrument furnished or to be furnished under this
      Agreement. The Company agrees to indemnify, defend and hold the Investors
      (following the Closing Date) harmless against and in respect of any and
      all claims, demands, losses, costs, expenses, obligations, liabilities or
      damages, including interest, penalties and reasonable attorney's fees,
      that it shall incur or suffer, which arise out of, result from or relate
      to any breach of this Agreement or failure by the Company to perform with
      respect to the representations, warranties or covenants contained in this
      Agreement or in any exhibit or other instrument furnished or to be
      furnished under this Agreement. In no event shall the Company or the
      Investors be entitled to recover consequential or punitive damages
      resulting from a breach or violation of this Agreement nor shall any party
      have any liability hereunder in the event of gross negligence or willful
      misconduct of the indemnified party. In the event of the failure of the
      Company to issue the Series A Preferred Stock and Warrants in violation of
      the provisions of this Agreement, the Investors, as their sole remedy,
      shall be entitled to pursue a remedy of specific performance upon tender
      into the Court an amount equal to the Purchase Price hereunder. The
      indemnification by the Investors shall be limited to $50,000.00. This
      Section 11.2 shall not relate to indemnification under the Registration
      Rights Agreement.

                         SECURITIES PURCHASE AGREEMENT
                                     PAGE 28


11.3. Headings. The headings contained in this Agreement are for reference
      purposes only and shall not affect in any way the meaning or
      interpretation of this Agreement.

11.4. Entire Agreement. This Agreement (together with the Schedule, Exhibits,
      Warrants and documents referred to herein) constitute the entire agreement
      of the parties and supersede all prior agreements and undertakings, both
      written and oral, between the parties, or any of them, with respect to the
      subject matter hereof.

11.5. Notices. All notices and other communications hereunder shall be in
      writing and shall be deemed to have been given (i) on the date they are
      delivered if delivered in person; (ii) on the date initially received if
      delivered by facsimile transmission or e-mail provided that any notice by
      facsimile or e-mail shall only be effective if receipt is acknowledged by
      the recipient; or (iv) on the on the date of delivery as shown on the
      return receipt, if mailed by registered or certified mail, return receipt
      requested with postage and other fees prepaid as follows:

                           If to the Company or Sinogas:

                           c/o Qingdao Sinogas General Machinery Corp.
                           45 Jinghua Road
                           Qingdao, Shandong, China, 266042
                           Attn: Bo Huang, CEO
                           Facsimile: (0532) 84851840
                           e-mail: QDZYTY@163.com

                           With a copy to:

                           Katsky Korins LLP
                           605 Third Avenue
                           New York, New York 10158
                           Attention: Asher S. Levitsky P.C.
                           Facsimile No.: (212) 716-3338
                           e-mail: alevitsky@katskykorins.com

                           If to the Investors:

                           at their respective addresses set forth in Schedule A

                         SECURITIES PURCHASE AGREEMENT
                                     PAGE 29


11.6. Severability. If any term or other provision of this Agreement is invalid,
      illegal or incapable of being enforced by any rule of law or public
      policy, all other conditions and provisions of this Agreement shall
      nevertheless remain in full force and effect so long as the economic or
      legal substance of the transactions contemplated hereby is not affected in
      any manner materially adverse to any party. Upon such determination that
      any such term or other provision is invalid, illegal or incapable of being
      enforced, the parties hereto shall negotiate in good faith to modify this
      Agreement so as to effect the original intent of the parties as closely as
      possible in an acceptable manner to the end that the transactions
      contemplated hereby are fulfilled to the extent possible.

11.7. Binding Effect. All the terms and provisions of this Agreement whether so
      expressed or not, shall be binding upon, inure to the benefit of, and be
      enforceable by the parties and their respective administrators, executors,
      legal representatives, heirs, successors and assignees.

11.8. Preparation of Agreement. This Agreement shall not be construed more
      strongly against any party regardless of who is responsible for its
      preparation. The parties acknowledge each contributed and is equally
      responsible for its preparation. In resolving any dispute regarding, or
      construing any provision in, this Agreement, there shall be no presumption
      made or inference drawn because of the drafting history of the Agreement,
      or because of the inclusion of a provision not contained in a prior draft
      or the deletion or modification of a provision contained in a prior draft.

11.9. Governing Law. This Agreement shall be governed by, and construed in
      accordance with, the laws of the State of New York, without giving effect
      to applicable principles of conflicts of law.

11.10. Jurisdiction. If any action is brought among the parties with respect to
      this Agreement or otherwise, by way of a claim or counterclaim, the
      parties agree that in any such action, and on all issues, the parties
      irrevocably waive their right to a trial by jury. Exclusive jurisdiction
      and venue for any such action shall be the federal and state courts
      situated in the City, County and State of New York. In the event suit or
      action is brought by any party under this Agreement to enforce any of its
      terms, or in any appeal therefrom, it is agreed that the prevailing party
      shall be entitled to reasonable attorneys fees to be fixed by the
      arbitrator, trial court, and/or appellate court if such party prevails on
      substantially all issues in dispute.

                         SECURITIES PURCHASE AGREEMENT
                                     PAGE 30


11.11. Preparation and Filing of SEC filings. The Investors shall reasonably
      assist and cooperate with the Company in the preparation of all filings
      with the SEC after the Closing Date due after the Closing Date.

11.12. Further Assurances, Cooperation. Each party shall, upon reasonable
      request by the other party, execute and deliver any additional documents
      necessary or desirable to complete the transactions herein pursuant to and
      in the manner contemplated by this Agreement. The parties hereto agree to
      cooperate and use their respective best efforts to consummate the
      transactions contemplated by this Agreement.

11.13. Survival. The representations, warranties, covenants and agreements made
      herein shall survive the Closing of the transaction contemplated hereby.

11.14. Third Parties. Except as disclosed in this Agreement, nothing in this
      Agreement, whether express or implied, is intended to confer any rights or
      remedies under or by reason of this Agreement on any persons other than
      the parties hereto and their respective administrators, executors, legal
      representatives, heirs, successors and assignees. Nothing in this
      Agreement is intended to relieve or discharge the obligation or liability
      of any third persons to any party to this Agreement, nor shall any
      provision give any third persons any right of subrogation or action over
      or against any party to this Agreement.

11.15. Failure or Indulgence Not Waiver; Remedies Cumulative. No failure or
      delay on the part of any party hereto in the exercise of any right
      hereunder shall impair such right or be construed to be a waiver of, or
      acquiescence in, any breach of any representation, warranty, covenant or
      agreement herein, nor shall any single or partial exercise of any such
      right preclude other or further exercise thereof or of any other right.
      All rights and remedies existing under this Agreement are cumulative to,
      and not exclusive of, any rights or remedies otherwise available.

11.16. Counterparts. This Agreement may be executed in one or more counterparts,
      and by the different parties hereto in separate counterparts, each of
      which when executed shall be deemed to be an original, but all of which
      taken together shall constitute one and the same agreement. A facsimile
      transmission of this signed Agreement shall be legal and binding on the
      party who delivered the Agreement by facsimile transmission; provided,
      that such party shall promptly deliver the signed Agreement by overnight
      courier services.

                         [SIGNATURES ON FOLLOWING PAGE]

                         SECURITIES PURCHASE AGREEMENT
                                     PAGE 31


      IN WITNESS WHEREOF, the Investors and the Company have as of the date
first written above executed this Agreement.

THE COMPANY:

FRANKLYN RESOURCES III, INC.


By:
   ---------------------------------
   Bo Huang, Chief Executive Officer

INVESTORS:


BARRON PARTNERS LP
By:  Barron Capital Advisors, LLC, its General Partner


By:
   ---------------------------------
Andrew Barron Worden
President
730 Fifth Avenue, 9th Floor
New York NY 10019

JCAR Funds Ltd.

By:
   ---------------------------------
     Jon R.Carnes, CEO


- ----------------------------------
Steve Mazur


- ----------------------------------
Ray Rivers


                                       33


                                   Schedule A





                                                                             NUMBER OF SHARES
                                                                             OF COMMON STOCK
                                                                             INTO WHICH NOTE            NUMBER OF SHARES
                                                                             AND/OR PREFERRED          UNDERLYING "A", "B"
NAME AND ADDRESS               AMOUNT OF INVESTMENT     INITIAL SHARES     STOCK IS CONVERTIBLE         AND "C" WARRANTS
- ----------------               --------------------     --------------     --------------------    -----------------------------
                                                                                         
Barron Partners LP                    $3,100,000             326,829            4,769,231          5,314,286/5,314,286/5,314,286
730 Fifth Avenue
9th Floor
New York, New York 10019
Attn: Andrew Barron Worden
e-mail:
abw@barronpartners.com
mcj@barronpartners.com

JCAR Funds Ltd.                          200,000              21,086              307,692                342,857/342,857/342,857
Attn: Jon R. Carnes

Steve Mazur                              100,000              10,543              153,846                171,429/171,429/171,429

Ray Rivers                               100,000              10,543              153,846                171,429/171,429/171,429







                         Schedule 4.3.1 - Capitalization






                                    Exhibit A

                                  Form of Note




                                    Exhibit B

                       Form of Certificate of Designation





                                    Exhibit C

                                Escrow Agreement




                                    Exhibit D

                          Registration Rights Agreement




                                    Exhibit E

                               Restated Articles






                                   Exhibit F-1

                                  $.85 Warrants





                                   Exhibit F-2

                                  $1.20 Warrant





                                   Exhibit F-3

                                  $1.75 Warrant